Results 181 to 190 of about 63,989 (248)

Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001. [PDF]

Res Pract Thromb Haemost
Nagy M, Gomes T, van Oerle R, Hacking TM, Magdelijns FJH, Henskens YMC, Reitsma P, Short G, Spronk HMH, Verhoef D.   +9 more
europepmc   +1 more source

Reversal of Paraneoplastic Non-Bacterial Thrombotic Endocarditis with Heparin and Targeted Cancer Therapy: A Case Report. [PDF]

Reports (MDPI)
Goetze C, Frost N, Hilgendorf I, Morris DA, Schneider-Reigbert M.   +4 more
europepmc   +1 more source

Protocol for a laboratory-developed chromogenic anti-Xa assay for rivaroxaban monitoring. [PDF]

MethodsX
Sun L, Lu W, Jiang G, Zhu C, Rong H, Lun L.   +5 more
europepmc   +1 more source

Safety and Efficacy of Direct Oral Anticoagulants Versus Standard Therapy for Venous Thromboembolism in Cancer Patients: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials. [PDF]

J Clin Med
Shahbar A, Alshahrani S, Alhifany A, Alnuhait M, Noor A, Almutairi A, Alhamdan FA, Alshamrani AA, Hakami AY.   +8 more
europepmc   +1 more source

Upadacitinib in refractory ulcerative colitis patients with high thromboembolic risk: two case reports. [PDF]

Front Immunol
Mo R, Yu S, Xu H, Hao J.
europepmc   +1 more source

Perioperative prevention of venous thrombosis with low-molecular-weight heparin versus rivaroxaban in elderly patients with hip fractures: A retrospective controlled study. [PDF]

Medicine (Baltimore)
He X, Chen H, Lou F, Yan C, Feng J.
europepmc   +1 more source

Deep vein thrombosis incidence after sequential Low-molecular-weight heparin and Rivaroxaban versus no prophylaxis in posterior cruciate ligament avulsion fractures. [PDF]

Sci Rep
Mithu MM, Wang TH, Huang J, Yang H, Haque MA, Xiong Y, Hartono R, Li H, Xiao J, Yang Z, Wang J, Wu Z, Chen Z.   +12 more
europepmc   +1 more source

Spontaneous spleen rupture due to rivaroxaban: a case report. [PDF]

Int J Surg Case Rep
Mozaffari SM, Zamani A, Mirhashemi SH, Hajinasrollah E.   +3 more
europepmc   +1 more source

Post-Pyloric Administration of Rivaroxaban With Therapeutic Monitoring in Pediatric Cardiac Patients: Experience in 3 Patients. [PDF]

J Pediatr Pharmacol Ther
Branstetter JW, Woodmansee S, Foland J, Zaki H, Townsend N, Zimowski KL, Woods GM.   +6 more
europepmc   +1 more source

Changes in the use of vitamin K antagonists and direct oral anticoagulants and impact on the incidence of oral anticoagulation-related intracerebral hemorrhage: population-wide prescription patterns in two 5-year cohorts. [PDF]

Ann Med
Tomppo L, Sallinen H, Lankinen O, Mastoras G, Georgiopoulos G, Poli S, Putaala J, Strbian D.   +7 more
europepmc   +1 more source